FGFR2 gene mutation in human prostate cancer : Close relation to loss of hormone dependency and therapeutic application
人类前列腺癌中的FGFR2基因突变:与激素依赖性丧失和治疗应用密切相关
基本信息
- 批准号:15591690
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Fibroblast growth factors (FGFs) and their receptors (FGFRs) expedite stromal-epithelial communication in development and homeostasis of the human prostate. Loss of resident epithelial cell FGFR2IIIb that responds to stromal FGF7 and FGF10 accompanies malignant progression of both model animal and human prostate tumors. We examined whether restoration of FGFR2IIIb by transfection in the malignant human prostate tumor PC-3 cell line restored cellular properties associated with less malignant tumors. Expression of FGFR2IIIb in PC-3 cells by transfection resulted in growth suppression in vitro and reduced tumor formation in vivo concurrent with increased cellular differentiation and apoptosis. Furthermore, we investigated the synergistic effects of radiation with the FGFR2IIIb in PC-3 cells. Radiation dramatically decreased the number of colonies in transfected PC-3 cells. The results indicate that restoration of FGFR2IIIb to the malignant human prostate epithelial cell prototype PC-3 restores properties associated with nonmalignant tumors and normal cells. This further suggests that epithelial cell resident, homeostasis-promoting FGFR2 may be involved in suppression of malignancy and that restoration may be a candidate for gene therapy of hormone-refractory prostate cancer.
成纤维细胞生长因子(FGF)及其受体(FGFR)在人前列腺的发育和稳态中促进基质-上皮通讯。响应于基质FGF 7和FGF 10的驻留上皮细胞FGFR 2 IIIb的丧失伴随模型动物和人前列腺肿瘤的恶性进展。我们研究了通过在恶性人前列腺肿瘤PC-3细胞系中转染FGFR 2 IIIb是否恢复了与恶性程度较低的肿瘤相关的细胞特性。通过转染在PC-3细胞中表达FGFR 2 IIIb导致体外生长抑制和体内肿瘤形成减少,同时增加细胞分化和凋亡。此外,我们研究了辐射与FGFR 2 IIIb在PC-3细胞中的协同作用。辐射显着减少转染PC-3细胞的集落数。结果表明,FGFR 2 IIIb对恶性人前列腺上皮细胞原型PC-3的恢复恢复了与非恶性肿瘤和正常细胞相关的性质。这进一步表明,上皮细胞驻留,促进稳态的FGFR 2可能参与抑制恶性肿瘤和恢复可能是一个候选的基因治疗的前列腺癌的肿瘤难治性。
项目成果
期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
IGFBP-rP1の発現回復によるヒト前立腺癌細胞の放射線感受性
通过恢复 IGFBP-rP1 表达来提高人前列腺癌细胞的放射敏感性
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kubo;N.;Hiroaki Yasumoto;Mituhiro Seki;望月英樹;石 光弘
- 通讯作者:石 光弘
線維芽細胞成長因子受容体2の発現回復によるヒト前立腺癌細胞の放射線感受性
通过恢复成纤维细胞生长因子受体2表达来提高人前列腺癌细胞的放射敏感性
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kubo;N.;Hiroaki Yasumoto;Mituhiro Seki;望月英樹
- 通讯作者:望月英樹
Restration of fibroblast growth factor receptor 2 increases radiosensitivity of human prostate cancer.
成纤维细胞生长因子受体 2 的重新抑制会增加人类前列腺癌的放射敏感性。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Inoue K;Chikazawa M;Fukata S;Yoshikawa C;Shuin T.;Nishimura K et al.;Nishimura Kazuo;Nishimura K;Nishimura K et al.;Inoue Hitoshi;Inoue H et al.;Inoue Hitoshi;西村和郎;Nishimura Kazuo;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;望月英樹;石 光弘;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;Mochizuki Hideki
- 通讯作者:Mochizuki Hideki
Restration of IGFBP-γ p1 increases radiosensitivity in hormone-refractory human prostate cancer.
重新抑制 IGFBP-γ p1 会增加激素难治性人类前列腺癌的放射敏感性。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Inoue K;Chikazawa M;Fukata S;Yoshikawa C;Shuin T.;Nishimura K et al.;Nishimura Kazuo;Nishimura K;Nishimura K et al.;Inoue Hitoshi;Inoue H et al.;Inoue Hitoshi;西村和郎;Nishimura Kazuo;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;望月英樹;石 光弘;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;Mochizuki Hideki;Mitsuhiro Seki;Mochizuki Hideki;Seki Mitsuhiro
- 通讯作者:Seki Mitsuhiro
Interaction of ligant-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer : a possible predictor of metastasis.
人前列腺癌中基质细胞衍生因子 1 和 CXC 趋化因子受体 4 之间配体受体系统的相互作用:可能的转移预测因子。
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Inoue K;Chikazawa M;Fukata S;Yoshikawa C;Shuin T.;Nishimura K et al.;Nishimura Kazuo;Nishimura K;Nishimura K et al.;Inoue Hitoshi;Inoue H et al.;Inoue Hitoshi;西村和郎;Nishimura Kazuo;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;望月英樹;石 光弘;Hiroaki Yasumoto;Hideki Mochizuki;Hideki Mochizuki;Mitsuhiro Seki;Mochizuki Hideki;Mitsuhiro Seki;Mochizuki Hideki;Seki Mitsuhiro;Mochizuki Hideki
- 通讯作者:Mochizuki Hideki
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUBARA Akio其他文献
MATSUBARA Akio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUBARA Akio', 18)}}的其他基金
Identification and clinical application of novel biomarkers for neuroendocrine differentiation of prostate cancer
前列腺癌神经内分泌分化新型生物标志物的鉴定及临床应用
- 批准号:
24592391 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification and translational research of transmenbrane and secretary proteins in prostate cancer
前列腺癌中跨膜蛋白和分泌蛋白的鉴定和转化研究
- 批准号:
21592046 - 财政年份:2009
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Implication of FGFR in loss of hormone dependency of prostate cancer and its application to new therapy for prostate cancer
FGFR在前列腺癌激素依赖性丧失中的意义及其在前列腺癌新疗法中的应用
- 批准号:
19591852 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel therapy for hormone-refractory prostate cancer
开发激素难治性前列腺癌的新疗法
- 批准号:
17591679 - 财政年份:2005
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic research on novel therapy for hormone-refractory prostate cancer with tyrosine kinase
酪氨酸激酶治疗激素难治性前列腺癌的基础研究
- 批准号:
13671654 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
BASIC RESEARCH OF NEW GENE THERAPY FOR PROSTATE CANCER WITH GROWTH FACTOR RECEPTOR
生长因子受体前列腺癌新基因治疗的基础研究
- 批准号:
10671474 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Role of a craniosynostosis associated fibroblast growth factor receptor mutation in extraocular muscles
颅缝早闭相关成纤维细胞生长因子受体突变在眼外肌中的作用
- 批准号:
10644569 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
The chaperone cycle of fibroblast growth factor receptor kinases in molecular detail
成纤维细胞生长因子受体激酶的分子伴侣循环的分子细节
- 批准号:
BB/W008017/1 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
Development of Predictive Markers for Sensitivity to Fibroblast Growth Factor Receptor Inhibitors Using Colorectal Cancer Stem Cells
使用结直肠癌干细胞开发成纤维细胞生长因子受体抑制剂敏感性的预测标记
- 批准号:
21K20818 - 财政年份:2021
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Structural mechanisms of fibroblast growth factor receptor signalling at the membrane interface
膜界面成纤维细胞生长因子受体信号传导的结构机制
- 批准号:
2271320 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Structural mechanisms of fibroblast growth factor receptor signalling at the membrane interface
膜界面成纤维细胞生长因子受体信号传导的结构机制
- 批准号:
BB/T508251/1 - 财政年份:2019
- 资助金额:
$ 2.24万 - 项目类别:
Training Grant
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
靶向成纤维细胞生长因子受体-2b 预防和治疗皮肤鳞状细胞癌。
- 批准号:
10318934 - 财政年份:2018
- 资助金额:
$ 2.24万 - 项目类别:
Development of the PET imaging probe targeting Fibroblast Growth Factor Receptor
靶向成纤维细胞生长因子受体的PET成像探针的开发
- 批准号:
17K10377 - 财政年份:2017
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Fibroblast Growth Factor Receptor in Craniosynostosis Syndromes
成纤维细胞生长因子受体在颅缝早闭综合征中的作用
- 批准号:
324026 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Studentship Programs
Investigating the mechanisms of fibroblast growth factor receptor 5 signalling complex distribution and dynamics using advanced live cell microscopy
使用先进的活细胞显微镜研究成纤维细胞生长因子受体 5 信号复合物分布和动态的机制
- 批准号:
460230-2014 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Postgraduate Scholarships - Doctoral
Fibroblast Growth Factor Receptor 2c and human testicular dysgenesis
成纤维细胞生长因子受体2c与人睾丸发育不全
- 批准号:
nhmrc : 1058548 - 财政年份:2014
- 资助金额:
$ 2.24万 - 项目类别:
Project Grants














{{item.name}}会员




